Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| PTC Therapeutics Inc. | 15 | 7 | 2 | 2 | €31.20 | €42.12 | 34.986% |
| Neurocrine Bioscience | 29 | 0 | 1 | 0 | €129.45 | €140.60 | 8.616% |
| Bruker Corp. | 8 | 1 | 1 | 0 | €70.40 | €84.02 | 19.352% |
| Merit Medical Systems | 17 | 0 | 0 | 0 | €74.00 | €86.90 | 17.428% |
| CONMED Corp. | 12 | 1 | 0 | 0 | €68.00 | €106.18 | 56.146% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €95.00 | €124.85 | 31.419% |
| Myriad Genetics | 6 | 2 | 0 | 0 | €23.00 | €24.18 | 5.134% |
| Bio-Techne Corp. | 10 | 0 | 0 | 0 | €76.50 | €75.94 | -0.737% |
| Amedisys Inc. | 14 | 0 | 0 | 0 | €85.50 | €92.26 | 7.906% |
| United Therapeutics | 18 | 0 | 0 | 0 | €253.50 | €287.40 | 13.373% |
| Exelixis Inc. | 18 | 0 | 0 | 0 | €19.37 | €26.01 | 34.261% |
| Arrowhead Pharmaceuticals Inc. | 14 | 2 | 0 | 0 | €23.06 | €52.03 | 125.607% |
| Alnylam Pharmace. | 36 | 0 | 0 | 0 | €137.60 | €236.30 | 71.728% |
| Halozyme Therapeutics Inc. | 14 | 0 | 0 | 0 | €41.95 | €50.33 | 19.983% |
| Insulet Corp. | 16 | 0 | 0 | 0 | €168.35 | €215.54 | 28.029% |
| Amicus Therapeutics Inc. | 6 | 0 | 0 | 0 | €8.75 | €17.78 | 103.191% |
| Masimo Corp. | 7 | 1 | 0 | 0 | €106.75 | €147.62 | 38.282% |
| Ensign Group Inc. | 9 | 0 | 0 | 0 | €110.00 | €116.99 | 6.357% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 0 | 0 | €31.40 | €38.99 | 24.168% |
| Xencor Inc. | 10 | 1 | 0 | 0 | €21.00 | €32.58 | 55.138% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 0 | 0 | €37.40 | €84.74 | 126.588% |
| Blueprint Medicines Corp | 2 | 0 | 0 | 0 | €95.42 | - | - |
| Novocure Ltd | 1 | 1 | 0 | 0 | €20.96 | - | - |
| Davita Inc. | 2 | 0 | 0 | 0 | €127.80 | €124.89 | -2.279% |
| Medpace Holdings Inc | 9 | 0 | 0 | 0 | €365.00 | €421.61 | 15.508% |